NCT05687136 2026-05-13Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid TumorsNational Cancer Institute (NCI)Phase 1 Recruiting66 enrolled